Gene · 23541
SEC14L2: SEC14 like lipid binding 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SEC14L2: SEC14 like lipid binding 2. Genes, record 23541. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23541
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O76054 | SEC14-like protein 2 | 403 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents43
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 62756 | O76054 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 18362 | O76054 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 9400 | O76054 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18362 | O76054 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 9400 | O76054 | Espacenet |
| JP 2023543041 A | 2023-10-12 | 20 | O76054 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 76775 | O76054 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 179746 | O76054 | Espacenet |
| KR 1020220042997 A | 2022-04-05 | 1 | O76054 | Espacenet |
| US 11136625 B2 | 2021-10-05 | 2 | O76054 | Espacenet |
1 to 10 of 43
See all 43 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,423
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SEC14L2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 16 | 2025 |
| R01AI044115 | Influences of HLA Class I Polymorphisms on immune responses | 12 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30AI060354 | Harvard University Center for AIDS Research | 5 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 5 | 2025 |
| T32AI007413 | Research Training in Experimental Immunology | 5 | 2025 |
| R01AI107301 | Genetic Viral and Host Adaptations to Breach Species Barriers of HCV | 4 | 2025 |
| R35CA241894 | Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies. | 4 | 2025 |
| T32AI007163 | Training Program in Basic Immunology | 4 | 2025 |
| ZIAAI001210 | Translation in Immunity | 4 | 2025 |
1 to 10 of 1,423Source NIH's project files
See all 1,423 nih grantsPapers1,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SEC14L2 contributes to tumor progression by enhancing USP5-driven RBM3 deubiquitination in pancreatic ductal adenocarcinoma. | Oncogene | 2026 | 42649370 | PubTator, text mining | PubMed |
| Exon junction complex and nuclear pore complex components preferentially govern the nuclear export of spliced lncRNAs. | Cell Death Discov | 2026 | 42420243 | PubTator, text mining | PubMed |
| Systematic discovery of pathogen effector functions across human pathogens and pathways. | Cell | 2026 | 42379168 | PubTator, text mining | PubMed |
| SEC14L2 couples chaperone-mediated autophagy to microtubule stability by targeting Stathmin 1. | Nat Commun | 2026 | 42270624 | PubTator, text mining | PubMed |
| The Pupil-Brain System at Rest: Spontaneous Pupil Fluctuations as Markers of Neuromodulatory and Network Dynamics. | Psychophysiology | 2026 | 42266026 | PubTator, text mining | PubMed |
| Gold nanoparticle-based electrophoresis-free colorimetric detection method for allele-specific PCR-SNP genotyping. | Anal Biochem | 2026 | 42082012 | PubTator, text mining | PubMed |
| Modulation of rhesus macaque killer cell immunoglobulin-like receptor-MHC I interactions by simian immunodeficiency virus peptides. | J Immunol | 2026 | 41984503 | PubTator, text mining | PubMed |
| Exploration of the proxiOME of large subunit ribosomal proteins reveals Acl1 and Bcl1 as cooperating dedicated chaperones of Rpl1. | Nucleic Acids Res | 2026 | 41909949 | PubTator, text mining | PubMed |
| Structural Design of T-Cell Epitope-Based mRNA Vaccine Constructs Determines the Quality of T-Cell Immunity and Protective Efficacy Against SARS-CoV-2 in Mice. | Vaccines (Basel) | 2026 | 41893817 | PubTator, text mining | PubMed |
| Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence. | PLoS Pathog | 2026 | 41855189 | PubTator, text mining | PubMed |
1 to 10 of 1,895
See all 1,895 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23541
GET https://conductscience.org/api/genes/v1/23541/patents?page=2